Global Cardiopulmonary Autotransfusion System Competitive Landscape Professional Research Report 2025

Research Summary

A cardiopulmonary autotransfusion system, also known as a cell saver or intraoperative blood salvage system, is a medical device used during surgical procedures to collect and process a patient＇s own blood for reinfusion. The system works by capturing and filtering blood lost during surgery, such as from the operative field or during cardiopulmonary bypass, and returning it back to the patient. The collected blood is processed to remove any contaminants, including debris and anticoagulants, and then reinfused to replenish the patient＇s blood volume. By utilizing the patient＇s own blood, cardiopulmonary autotransfusion reduces or eliminates the need for donor blood transfusions, minimizing the risks associated with transfusion reactions and transmission of infections. It is commonly used in cardiac surgery, orthopedic procedures, and other surgeries where significant blood loss is anticipated. Cardiopulmonary autotransfusion systems contribute to improved patient outcomes, reduced need for allogeneic blood transfusions, and cost savings in the healthcare setting.

According to DIResearch's in-depth investigation and research, the global Cardiopulmonary Autotransfusion System market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Cardiopulmonary Autotransfusion System include Haemonetics, Medtronic, LivaNova, Fresenius Kabi, Terumo, Wandong Health Sources etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Cardiopulmonary Autotransfusion System. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Cardiopulmonary Autotransfusion System market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Cardiopulmonary Autotransfusion System market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Cardiopulmonary Autotransfusion System industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Cardiopulmonary Autotransfusion System Include:

Haemonetics

Medtronic

LivaNova

Fresenius Kabi

Terumo

Wandong Health Sources

Cardiopulmonary Autotransfusion System Product Segment Include:

Intraoperative Autotransfusion Systems

Postoperative Autotransfusion Systems

Cardiopulmonary Autotransfusion System Product Application Include:

Cardiac Surgeries

Orthopedic Surgeries

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Cardiopulmonary Autotransfusion System Industry PESTEL Analysis

Chapter 3: Global Cardiopulmonary Autotransfusion System Industry Porter’s Five Forces Analysis

Chapter 4: Global Cardiopulmonary Autotransfusion System Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Cardiopulmonary Autotransfusion System Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Cardiopulmonary Autotransfusion System Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Cardiopulmonary Autotransfusion System Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Cardiopulmonary Autotransfusion System Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Cardiopulmonary Autotransfusion System Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Cardiopulmonary Autotransfusion System Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Cardiopulmonary Autotransfusion System Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Cardiopulmonary Autotransfusion System Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources